Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Doxepin

A tricyclic antidepressant discovered in Germany in 1963 and introduced in the United States in 1969; besides depression, it is used at very low doses for insomnia and, as a cream, for itching. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It is considered one of the most potent H1 antihistamines of all: this action, more than the antidepressant one, explains its use for insomnia, approved in the United States in 2010.

Doxepin HydrochlorideGo to the active ingredient →
NordoxepinImpurityNordoxepinCat. No. P-D181-029CAS 1225-56-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.